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Abstract
In 2006, breast cancer was the third leading cause of death in American women; however, more
women survive breast cancer than any other type of cancer. As the disease progresses, it is
important to know how one's health-related quality of life (QOL) is affected for those who receive
treatment, those who survive, and those who remain disease-free. The purpose of this study was
to summarize the benefits, challenges, and barriers of QOL measurement for female breast cancer
patients. A PubMed literature search was conducted using the terms "quality of life" and "breast
cancer." The search was then refined with terms related to QOL assessment instruments. The
research team reviewed over 100 of the 2,090 articles identified.
From the results, a detailed outline of QOL instruments is presented, and the effectiveness of QOL
instruments is discussed. In the current literature review, both generic and breast cancer specific
QOL instruments, examining computerized and paper-and-pencil versions, are explained as well as
the advantages, acceptability, and problems of these assessments. Potential barriers to
implementation are also discussed. The implementation of QOL assessment tools in breast cancer
clinical practice is discussed, with evidence detailing how such tools would benefit patients.
Background
The burden of breast cancer
Breast cancer is costly, both in human and economic
terms. In 2006, breast cancer was the third leading cause
of death in American women after heart disease and lung
cancer, accounting for more than 41,000 deaths [1].
Breast cancer also accounted for 31% of all cancers in
females and 15% of all cancer-related deaths for women
in the U.S. in 2006 [2]. Even though heart disease is the
leading cause of death in females, breast cancer is the dis-
ease many women fear the most [3]. It is estimated that
one in eight American women will be diagnosed with
breast cancer at some point in their lives [4]. The number
of women with breast cancer is increasing annually. Each
year, over 1.1 million females worldwide are diagnosed
with breast cancer and 410,000 women die from the dis-
ease[5]. According to the American Cancer Society, breast
cancer was the number one newly diagnosed disease for
women in 2005 and accounted for 31% of all newly diag-
nosed cases in 2004. More than 9.5 million women were
learning to cope with a progressive disease, going through
curative treatment, or living cancer-free after treatment in
2004 [6].
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Breast cancer is an economic burden, with its cost of ill-
ness being comprised of direct cost, morbidity cost, and
mortality cost. Over extended periods, cancer expendi-
tures are increasing at a similar rate to overall health costs
[7]. According to the National Institutes of Health, breast
cancer was estimated to cost $209.9 billion a year in 2005,
of which $118.4 billion was due to mortality cost (lost
productivity by the death of patients), $74.0 billion was
due to direct medical costs (money spent for healthcare),
and $17.5 billion was due to morbidity cost (the cost of
lost productivity due to illness) [8]. Longitudinal data on
cancer costs exist on the SEER-Medicare linked database, a
resource for policy makers and analysts, which helps to
represent the costs of cancer based on its prevalence and
incidence [7].
The effects of breast cancer on patients
Breast cancer patients experience physical symptoms and
psychosocial distress that adversely affect their quality of
life (QOL). QOL generally consists of a number of
domains including physical functioning, psychological
well-being (such as levels of anxiety and depression), and
social support. Their breast cancer experiences vary, but
could include the following phases: diagnosis, primary
treatment, genetic risk and its psychological management,
special issues related to non-invasive breast cancer, recur-
rence, completing treatment and re-entry to normal liv-
ing, survivorship, and palliation for advanced cancer [9].
Chemotherapy, for example, is one form of treatment that
can cause physical and psychological problems that
adversely affect patient QOL [10]. Other effects of cancer
include anger, grief, suffering, and pain [11]. While adapt-
ing to cancer, many patients may have questions about
their illness, but are apprehensive about speaking to their
physician [11].
Psychosocial problems compound the hardships of phys-
ical symptoms and affect the QOL of breast cancer
patients. The psychosocial distress that patients upon
diagnosis feel can affect their treatment because these
symptoms can be overwhelming. Many women who are
newly diagnosed with breast cancer might feel sad, anx-
ious, shocked, and scared. Psychological treatments could
help patients come to terms with their emotions and treat
mental illnesses they may develop, including depression,
panic disorders, and anxiety disorders [9].
Sharpe et al. reported that another important aspect of liv-
ing with cancer is the process a person uses to adjust to his
or her illness due to acclimation of the illness. Specifically,
this occurs when a person shifts his or her priorities and
expectations during assessments to be in line with his or
her differing circumstances [12]. They found that patients
who were recently diagnosed with metastatic cancer
reported more areas of their life as being important to
their QOL each time they were asked. In particular, almost
half (47%) of the participants shifted the areas they
described as being the most important between the initial
questioning and the second questioning three months
later. Forty-three percent shifted their responses between
the second and third questioning (six months after the
initial questioning) [12].
Breast cancer treatments and quality of life
Objective tumor response and survival traditionally have
been used to assess cancer treatment outcomes. Two
major changes in cancer medicine have occurred over the
past decade. The first is recognition that the patient's well-
being is important to cancer treatment. Another is the use
of QOL and psychosocial questionnaires to assess their
well-being. Since the time of Hippocrates, QOL has been
an implied medical outcome [13,14]. In 1948, Karnofsky
et al. [15] reported the first effort of physicians to assess
systematically the effect of cancer treatments on patients'
QOL, not just on their quantity of life. QOL instruments
currently are being used in clinical trials to predict sur-
vival, response to treatment, and to screen for psycholog-
ical morbidity [16].
Understanding the effect of breast cancer treatment on a
patient's QOL has been a central clinical and research
question. For the past quarter century, psychosocial and
emotional concerns have been addressed in intervention
research of women with breast cancer. Findings by Ganz
and Goodwin revealed that with the number of survivors
growing in recent years, breast cancer patients have been
assessed with multiple QOL instruments in order to com-
pare the effects of breast cancer and its treatments to those
of people with other chronic illnesses as well as to healthy
women [17].
One important issue regarding the implementation of
QOL assessment is the use and utilization of validated
instruments within a clinical setting, not specifically for
research purposes[18]. QOL consists of several domains
including physical functioning, psychological well-being
(such as levels of anxiety and depression), and social sup-
port. Donaldson [18] states that patients report both pos-
itive and negative effects of their diagnosis and treatment.
QOL assessments can be used in diagnosis, predicting
prognosis, assessment, patient monitoring, clinical deci-
sion-making, communication, and treatment. Other uses
include designing system intervention, allocating
resources and research efforts, training health care person-
nel, and reducing costs [18,19]. Which specific instrument
is chosen is based on: the purpose of the assessment, the
patient population targeted, and the timing and frequency
of the administration of a given instrument [18].Health and Quality of Life Outcomes 2007, 5:24 http://www.hqlo.com/content/5/1/24
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Instrumental in reviewing breast cancer outcomes, Man-
delblatt and colleagues (2004) [20] conducted a meta-
analysis utilizing 230 articles from 1990 to 2000. Primary
conclusions drawn from this study include the majority of
articles utilized health-related QOL outcomes, no single
instrument was utilized in more than 10% of all the arti-
cles, most articles had a primarily white population and
did not focus on elderly breast cancer patients, and meth-
odological flaws were prevalent throughout the studies
analyzed.
The importance of meeting the needs of breast cancer 
patients
Studies by Ganz and Goodwin found that when assessing
the QOL of women with breast cancer, their stage of dis-
ease should be taken into account and include: women
with non-invasive breast cancer, women who are newly
diagnosed with early stage breast cancer or advanced local
breast cancer, women surviving disease-free beyond the
first course of primary treatment, survivors of five years or
more, women with a first recurrence of breast cancer after
a disease-free interval, and women living and dying with
advanced metastatic disease [17].
Some cancer patients may be unwilling to reveal their con-
cerns about their disease and treatment [21], and may be
even more unwilling to raise psychological problems they
may develop throughout the course of their disease [22].
While patients want their health care providers to inquire
about their daily functioning and well-being, health care
providers may seldom do so [23-25]. However, if physi-
cians were not concerned about their patients' outcomes,
there would be no reason for follow-up visits [18]. Oncol-
ogists, nurses, and psychosocial staff agree that QOL is an
important variable to consider in cancer treatment [26-
28]. However, patients and physicians frequently have dif-
ferent priorities regarding treatment and the effect that the
illness will have on a patient's life and possible outcomes.
Employing the patients' views into the decision process
would not only empower patients, but also could
improve satisfaction and compliance with treatment.
Sprangers and Schwarz stated that patient outcomes could
be improved further by utilizing QOL assessments to
detect and treat functional and psychological issues that
have not been brought previously to the forefront. People
whose expectations are met in the areas they consider as
most important are those who report a good QOL [29].
The purpose of this review
The primary purpose of this paper is to expand the work
of Mandelblatt and colleagues [20] into recent years,
focusing on QOL assessments and new research possibili-
ties utilizing computerized QOL assessments. This review
aims to add to the scientific literature by revealing the
answers to five significant questions about the role of
QOL assessments for breast cancer patients and suggesting
future directions for the field. First, how would the imple-
mentation of QOL assessments into clinical practice ben-
efit the overall QOL of patients? Second, to what degree
have healthcare providers found QOL assessments accept-
able to utilize in clinical practice? Third, how can QOL
data be utilized to benefit patients? Fourth, how can bar-
riers to implementation be overcome? Fifth, how can
technology improve the accuracy of these assessments and
facilitate their implementation into clinical practice?
Methods
A systematic review was conducted by searching the
PubMed database, limiting the research to the years
1995–2005, and using the following keywords: quality of
life and breast cancer (in all of the searches) in conjunc-
tion with computer, software, touch-screen, program,
assessment, questionnaire, instrument, and patient-
reported outcomes separately within each search. Over
2,090 articles were found meeting the criteria. The
research team reviewed over 100 of the most relevant arti-
cles for inclusion in this report.
Inclusion criteria included articles published in a peer-
reviewed journal, specifically utilizing QOL assessments
with chronically ill patients (particularly female breast
cancer patients), articles examining the use of QOL assess-
ments in randomized trials, studies involving both paper
and pencil versions of the instruments as well as compu-
terized versions of the assessments, and literature reviews
concerning QOL of breast cancer patients. Exclusion crite-
ria included comments/letters and papers published in a
language other than English.
The second stage of the research involved searching the
PubMed database between the years 1989–2006 using the
following keywords: quality of life and breast cancer (in
all of the searches), in addition to advantages, acceptabil-
ity, patient acceptability, problems, barriers, and imple-
mentation. The 20 most relevant articles from this search
were included in the study.
Results
Because of the complexity of breast cancer and the diverse
nature of its patient population, no one instrument is
both comprehensive and sensitive enough to report clini-
cally meaningful changes in all outcomes across all phases
of care and has satisfactory respondent or provider bur-
den. However, based on Mandelblatt's et al. [20] compre-
hensive meta-analysis of breast cancer outcomes
literature, they believe it is possible to develop a "core" set
of questions to measure breast cancer outcomes. After
reviewing the articles retrieved in the PubMed search, 21
QOL instruments were identified as being the most used
assessments within the breast cancer population. EachHealth and Quality of Life Outcomes 2007, 5:24 http://www.hqlo.com/content/5/1/24
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instrument is briefly described below and a summary of
these instruments can be found in Appendix A (see Addi-
tional file 1).
Description of QOL instruments
Beck Depression Inventory (BDI) [30]
The BDI is a 21-item self-administered scale designed to
measure depression. It has one domain, which is depres-
sion.
The Breast Cancer Chemotherapy Questionnaire (BCQ) [31]
The BCQ is a 30-item interviewer-administered question-
naire developed to measure outcomes of women with
stage II breast cancer receiving adjuvant chemotherapy. It
is comprised of seven domains (consequences of hair loss,
positive well-being, physical symptoms, trouble and
inconvenience, fatigue, emotional dysfunction, and nau-
sea) [31].
Breast Cancer Prevention Trial Symptom Checklist (BCPT) [32,33]
The BCPT is a 43-item self-administered questionnaire
designed to examine the physical and psychological
symptoms associated with menopause and Tamoxifen
usage. This questionnaire is comprised of eight symptoms
(hot flashes, nausea, bladder control, vaginal problems,
musculoskeletal pain, cognitive problems, weight prob-
lems, and arm problems).
Cancer Needs Questionnaire – Short Form (CNQ-SF) [34]
The CNQ-SF is a 32-item self-administered questionnaire
developed to assess cancer patients' needs. It is comprised
of five domains (psychological, health information, phys-
ical and daily living, patient care and support, and inter-
personal communication) [35].
Cancer Rehabilitation Evaluation System – Short Form (CARES-SF) 
[36]
The CARES-SF is a 59-item self-administered question-
naire developed to assess patients' cancer-related prob-
lems. The assessment is comprised of six domains
(physical, psychosocial, medical interaction, martial, sex-
ual, and global) and is scaled on a five point Likert scale
ranging from 0 (Not at all) to 4 (Very much) [37].
Center for Epidemiologic Studies Depression Scale-10 (CES-D) [38]
The CES-D-10 is a short 10-item self-administered scale
designed to measure depression[39]. The 20-item CES-D
is one of the most common screening tests for depression.
Edmonton Symptom Assessment System (ESAS) [40]
The ESAS is a 9-item self-administered questionnaire
designed to measure a variety of symptoms. This ques-
tionnaire is comprised of nine domains (pain, tiredness,
nausea, depression, anxiety, drowsiness, appetite, well-
being, and shortness of breath) and is scaled using a visual
analog scale[41].
European Organization for Research and Treatment of Cancer QOL 
Cancer Specific Version (EORTC QLQ-C30)[42]
The EORTC QLQ-C30 is a 30-item self-administered can-
cer specific questionnaire designed to measure QOL in the
cancer population. The assessment is comprised of nine
domains (physical, role, cognitive, emotional, social,
fatigue, pain, nausea and vomiting [43].
European Organization for Research and Treatment of Cancer QOL 
Breast Cancer Specific Version (EORTC QLQ-BR23) [44]
The EORTC QLQ-BR23 is a 23-item self-administered
breast cancer specific questionnaire, usually administered
with the EORTC QLQ-C30, designed to measure QOL in
the breast cancer population at various stages and with
patients with differing treatment modalities. The assess-
ment is comprised of five domains (body image, sexual-
ity, arm symptoms, breast symptoms, and systemic
therapy side effects) [44].
Functional Assessment of Cancer Therapy – Breast Symptom Index 
(FACT-B – FBSI) (44 items) [45,46]
The FACT-B – FBSI is a 44-item self-administered ques-
tionnaire specific to breast cancer patients. The assessment
is comprised of six domains (physical well-being, social/
family well-being, relationship with doctor, emotional
well-being, functional well-being, and additional con-
cerns) [45].
Functional Assessment of Cancer Therapy – Endocrine Symptom 
Subscale (FACT-ES) [47]
The FACT-ES is an 18-item self-administered question-
naire, usually administered with the FACT-B, focusing on
endocrine concerns experienced during breast cancer
treatment [47].
Functional Living Index – Cancer (FLIC) [48]
The FLIC is a 22-item self-administered questionnaire
designed to assess the effect cancer treatment and symp-
toms have on functional ability in all areas of life. This
questionnaire is comprised of five domains (physical
functioning, mental functioning, social functioning, gen-
eral health/well-being, and gastrointestinal symptoms)
[48].
Geriatric Depression Scale – Short Form (GDS-SF)[49]
The GDS-SF is a 15-item self-administered questionnaire
designed to assess depression in the elderly. This instru-
ment is comprised of four domains (positive mood; sad
mood; boredom, memory problems, and energy level;
and staying at home) [50].Health and Quality of Life Outcomes 2007, 5:24 http://www.hqlo.com/content/5/1/24
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Hospital Anxiety and Depression Scale (HADS) [51]
The HADS is a 14-item self-administered questionnaire
developed to measure anxiety and depression. The ques-
tionnaire is comprised of two domains (anxiety and
depression) [52].
Life Satisfaction Questionnaire (LSQ) [53]
The LSQ is a 32-item self-administered questionnaire
developed to measure one's general sense of satisfaction
with life as it relates to school, relationships, leisure time,
religious practices, and overall health specifically for
women with breast cancer. This questionnaire is com-
prised of six domains (quality of family relation, physical
symptoms, socioeconomic situation, quality of daily
activities, sickness impact, and quality of close friend rela-
tion) [53].
Medical Outcome Study's 36-Item Short Form Health Survey (SF-36) 
[54]
The SF-36 is a 36-item self-administered questionnaire
developed to assess health-related QOL. It is comprised of
eight domains (physical functioning, role limitations due
to physical health, role limitations due to emotional
problems, energy/fatigue, emotional well-being, social
functioning, bodily pain, and general health) [55].
Rotterdam Symptoms Checklist (RSCL) – Modified[56]
The RSCL-Modified is a 28-item self-administered ques-
tionnaire developed to assess symptom-related distress
among cancer patients. This instrument is comprised of
two domains (physical distress and miscellaneous varia-
bles) [56].
Satisfaction with Life Domains Scale for Breast Cancer (SLDS-
BC)[57]
The SLDS-BC is a 32-item self-administered questionnaire
comprised of five domains (social functioning, appear-
ance, physical functioning, communication with medical
providers, and spirituality) [57].
Spitzer Quality of Life Index (QL-Index)[58]
The QL-Index is a 5-item interviewer-administered or self-
administered questionnaire designed to assess health out-
comes of those with cancer and other chronic diseases.
The questionnaire is comprised of five domains (activity,
daily living, health, support, and outlook) [58].
World Health Organization Quality of Life – Brief Version 
(WHOQOL-BREF) [59]
The WHOQOL-BREF is a 26-item self-administered
assessment designed to examine domain level profiles
assessing quality of life. This assessment is comprised of
four domains (physical health, psychological, social rela-
tionships, and environment) [60].
Zung Self-Rating Depression Scale (SDS) [61]
The Zung SDS is a 20-item self-administered scale
designed to measure depression [62].
Benefits of QOL assessments
Overall benefits of QOL assessments
The overall benefits of QOL assessments include their use
in preventive intervention and their potential to inform
clinicians about the patient's illness as well as how certain
treatments may affect the QOL of that patient. Jacobsen et
al. report that an understanding of QOL also improves
communication between physicians and patients [63].
Evaluation of the advantages of QOL assessments has led
the National Institutes of Health and the National Cancer
Institute to conclude that QOL measures should be incor-
porated into research studies when possible.
Benefits of QOL assessment in clinical practice
Magruder-Habib et al. [64] and Rubenstein et al. [65]
reported significantly more changes to treatment in the
intervention group, participants who were assessed using
a QOL instrument, as compared to the control group, who
were not assessed. In one study, physicians took more
action on the patient-reported categories listed in the
chart of the experimental group as compared to the con-
trol group (73% and 68.5%, respectively) [64]. Gold and
Baraff [66] and Mazonson et al. [67] reported significantly
more referral rates to other professionals in the interven-
tion group as compared to the control group. One study
reported that physicians found the questionnaires to be
more useful for those patients who had a worse initial
functioning score [24].
In a study by Detmar et al. [68], almost 97% of the
patients stated that the QOL profile provided an accurate
summary of their functioning and well-being. Fifty-seven
percent reported their physicians used the profile explic-
itly during their visits, 79% believed the profile enhanced
physician awareness of their health problems, and 87%
thought it would be useful to introduce a QOL assessment
as a standard part of the outpatient clinical experience.
With regard to the length of time for an office visit, this
study did not find statistical significance in the length of
office visit; however, the control group visits took longer
than the intervention group (20.4 minutes vs. 19.8 min-
utes, respectively) [68].
Role of QOL assessment in facilitating communication
A study conducted by Mazonson et al. [67] reported an
increase in patient-physician communication in the inter-
vention group as compared to the control group. Wagner
et al. [24] found a moderate percentage (67%) of patients
reported positive attitudes about completion of the assess-
ment as well as sharing their feelings and physical abilities
with their physician. Furthermore, the study reported thatHealth and Quality of Life Outcomes 2007, 5:24 http://www.hqlo.com/content/5/1/24
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more patients wanted physicians to inquire about their
feelings (80%) as opposed to their physical abilities
(71%). Street et al. [69] reported that most patients
wanted physicians to inquire about their vitality, physical
functioning, and role limitations due to physical issues,
and only half of the patients felt that these problems were
currently being discussed. Other studies reported that at
least a moderate percentage of physicians said that they
had made changes within their practice since the imple-
mentation of a QOL instrument [70-72].
Studies have reported that QOL issues in intervention
groups were discussed significantly more frequently when
QOL assessments, specifically the EORTC-C30, were used
compared to control groups (no QOL assessment used)
[68,73]. Taenzer et al. revealed that patients reported 49%
of the QOL items they identified were addressed by their
physician during their clinical visit [73]. In Detmar et al.
[68], 10 of the 12 QOL issues were discussed more fre-
quently in the intervention group; however, only three
issues reached statistical significance: social functioning,
fatigue, and dyspnea. Intervention group physicians were
able to identify a larger percentage of patients with mod-
erate to severe QOL issues, such as problems with daily
activities, feelings, social activities, pain, and fatigue, com-
pared to the control group's physicians, who only could
identify problems in daily activities and pain. The most
noteworthy increase was the discussion of less observable
issues, such as social functioning, or those that are more
diffuse and long-term in nature, such as fatigue, that are
usually left unaddressed by physicians [68].
In the same study by Detmar et al. [68], patients in the
intervention group received significantly more counseling
from their physicians on how to manage their health
problems than did the control group. In examining
patient satisfaction, the only statistically significant differ-
ence between the two groups was shown for the amount
of emotional support received, with the intervention
group receiving more than the control group. Overall,
patients in the intervention group exhibited a statistically
significant improvement over time in regards to mental
health and role functioning. All of the physicians stated
that the profiles offered a useful overall representation of
their patient's health-related experiences and indicated
that it also assisted with communication, particularly in
regards to psychosocial topics and "unexpected" symp-
toms such as sleep disturbances [68].
Role of QOL assessment in clinical decision-making
Bendsten et al. reported that physicians have reported that
a holistic approach, including QOL, is necessary when
treating patients [74]. Greenhalgh and Meadows, Di Maio
and Perrone, and Le et al. have found that one important
benefit of QOL assessment is to encourage shared deci-
sion making and to facilitate communication between
physicians and patients[25,75,76] by providing feedback
to the patients regarding their progress, goals, and expec-
tations [18]. According to Donaldson as well as Deyo and
Carter, QOL measures can also be used for monitoring
disease progression (i.e., survival) or response to treat-
ment (i.e., toxicity, side effects, and adverse effects)
[18,77]. Other potential benefits of QOL measurement
include detection of treatable issues that are normally
overlooked during patient care such as education about
the disease and nutritional counseling as well as obtaining
a baseline upon entering care or therapy. QOL measure-
ment could potentially be helpful in monitoring a reduc-
tion of functional capacity and in identifying other
physical and emotional problems. Donaldson as well as
Bendsten et al. and Le et al. have found that timely feed-
back can result in a reduction in anxiety, thus preventing
fewer visits and calls with improved satisfaction with care
[18,74,76]. If patients were to take on the role of more
self-management with the use of QOL assessment's
implementation, it could lead to more efficient use of
resources, and thereby reduce costs [18].
Detmar et al. [68] (2002) discovered that even though all
of the physicians reported they would like to continue
using QOL assessments in their daily practice, several sug-
gested the need for more tailored assessments to specific
patient groups, such as the site of pain and use of pain
medication for patients with bone metastases [68].
Another study by Middeke et al. found that all the partic-
ipating physicians reported the QOL profiles were easy to
understand and clinically relevant, and more than half of
the physicians indicated the profiles had provided them
with additional information that led to a more complete
diagnosis [78].
Treatment plans can also be altered or contingent upon an
individual's QOL. Di Maio and Perrone [75] found that
elderly cancer patients prefer treatments that potentially
improve their QOL over that of their survival; only 22%
chose chemotherapy if a hypothesized survival benefit of
three months was given, and 68% chose chemotherapy if
it would substantially reduce symptoms, even if no signif-
icant increase in survival was expected.
Benefits of non-visit based assessment platforms
A study by Donaldson revealed that the Internet, comput-
ers, telephones, and hand held devices now allow QOL
assessment to become non-visit based. These platforms
provide a highly efficient, timely, and individualized
approach to QOL assessment, and provide better privacy
and confidentiality.
By allowing patients to complete password-protected
QOL assessments whenever they are away from doctors'Health and Quality of Life Outcomes 2007, 5:24 http://www.hqlo.com/content/5/1/24
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offices and are experiencing symptoms, patients may sub-
mit their reports at any time of the day. PRO reports sub-
mitted during the day can be reviewed immediately by
physicians, and those submitted after office hours would
be viewed the next morning. By evaluating PRO reports,
physicians may triage patients to determine which cases
are most urgent and to decide on appropriate treatment
customized for each patient. Triage is usually performed
by using a threshold score, with people above the deter-
mined score to be given more urgent care. These methods
also allow for ongoing monitoring of patient treatment
and management to evaluate their effectiveness [79].
Acceptability of QOL assessments
Overview
Healthcare providers and patients alike find QOL assess-
ments acceptable in helping breast cancer patients to over-
come areas of QOL that have been affected by the disease.
Several studies have demonstrated the reasons why the
implementation of QOL assessments is found acceptable
by physicians.
Healthcare provider acceptability
Finlay and Dunlap as well as Bezjak et al. report that
healthcare providers agree that QOL assessments are valu-
able in clinical practice [26,28]. Bezjak et al[28] (2001)
conducted a survey of 271 Eastern Cooperative Oncology
Group (ECOG) physicians and found that 94% of
respondents disagreed with the statement "I do not plan to
incorporate QOL data in my practice." In addition, 75%
disagreed with the statement "I would only be willing to
use formal QOL assessment if required to do so by my
institution or regulatory body." Eighty-two percent indi-
cated it was likely that they would increase their use of
QOL in the care of future patients [28].
Several studies, including those done by Wagner et al.,
Wasson et al., and Moore et al., have reported at least a
moderate percentage of physicians had positive attitudes
about the implementation and feasibility of QOL assess-
ments within routine practice [24,70,80]. Moore et al.
[80] and Rubenstein et al. [71] showed a large percentage
of internists and family physicians reported the QOL
information as accurate and would use the instrument
with other patients in the future. Other studies examined
the physician's perception of the efficacy of the measures
in routine practice. All of them found at least a moderate
percentage of physicians who showed positive attitudes
[24,70-72,80,81].
Another study by Taenzer et al. found an overwhelmingly
positive response from oncology nurses regarding the use-
fulness of a computer-administered questionnaire's gen-
erated report, with 91% stating the report indicated
appropriate concerns, 91% stating it guided the clinical
interaction, 82% stating it promoted communication,
and 74% stating the report indicated areas of need for the
patients [82]. Velikova reported that when assessing the
oncologists' checklists, it was found the clinicians thought
the health-related QOL information was very useful in
43% of the visits, somewhat useful in 28% of the visits, a
little useful in 21% of them, and not useful in 9% of the
visits [83].
Patient acceptability
Stiggelbout et al. [84] found that it was feasible to use
questionnaires to evaluate patients' feelings regarding
quality of life versus quantity of life. Apolone et al. [85]
examined the acceptability of QOL questionnaires among
patients and found the response rate was 64% with few
missing items on the questionnaires. These results provide
an example of the acceptability of QOL questionnaires for
patients, and the EORTC QLQ-C30 in particular for this
study [85].
To be acceptable, questionnaires must be sensitive to the
needs of patients. Cancer patients found assessments that
asked questions in the form of words rather than only
numbers and had fewer answer options to be acceptable.
Additionally, studies by Pijls-Johannesma et al. have
revealed that questionnaires that did not ask questions
that were overly personal, sensitive, or irrelevant were
favored by respondents [86].
Problems with QOL assessments and barriers to 
implementation
Overview
Morris et al. [87] found that although 80% of healthcare
professionals believed that information obtained from
QOL assessments is valuable, fewer than 50% of them
implemented QOL assessments in their practice. The
researchers attributed the problems to an unwillingness of
physicians to use the assessments because they are consid-
ered unnecessary, the belief of some practitioners that
they do not have appropriate instruments, and logistical
problems such as limited resources and time [87].
Problems due to characteristics of QOL assessments
Even though QOL information is clinically valuable, phy-
sicians often view it as providing "soft" data that does not
permit "hard" measurement such as that obtained in the
laboratory. Barriers to implementation can also arise due
to the types of questions asked. Questions that are too per-
sonal, sensitive, or irrelevant are more likely to be omitted
by respondents. For example, some questionnaires ask
respondents about their careers. Pijls-Johannesma et al.
report that such questions are irrelevant in the elderly
population, as many respondents are retired [86].Health and Quality of Life Outcomes 2007, 5:24 http://www.hqlo.com/content/5/1/24
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Problems with implementation related to patient population
Potential problems with QOL assessments can occur prior
to their implementation in clinical practice. Few studies
have yet assessed QOL on long-term survivors (greater
than 5 years after diagnosis), as most assess patients one
year after diagnosis. It is necessary to include long-term
survivors who are willing to participate in the study so
that their views can be fully integrated into the initial
instrument development.
Particularly in the elderly, QOL assessments can be diffi-
cult to incorporate into a clinical practice because there
are a higher rate of illiteracy, worse compliance with ques-
tionnaires, cognitive disorders, comorbidities, and non-
validated instruments within this population. Di Maio
and Perrone [75] found a decrease in compliance in the
elderly, as only 21.5% of the elderly patients completed
the QOL questionnaire administered after six months,
whereas 37.2% of younger patients completed the ques-
tionnaire. As mentioned above, Detmar et al. [68] did not
find any significant difference in the length of time
between the control visit and the intervention visit.
Problems with implementation related to their use by healthcare 
professionals
Findings by Deyo and Carter reveal that physicians are less
familiar with QOL assessments than with imaging or
physiological tests and often are unfamiliar with how to
interpret the results or respond to them [77]. Limited time
is often mentioned as one of the problems associated with
utilizing a QOL assessment in daily practice; however, one
study by Maguire et al. found that it only took an average
of 60 seconds longer for the physician to extract all of the
patient's current problems [88].
Problems with implementation due to logistical and resource 
constraints
Gotay et al. state that other barriers to implementation of
QOL assessments include staff and financial limitations
with respect to the amount needed to produce high-qual-
ity data, quality control, monitoring procedures, data col-
lection, and submission [89]. Some researchers believe
that interviews or semi-structured interviews conducted
by professionals should be used instead of self-assess-
ments to minimize the amount of missing data [11].
As reported by Velikova et al. and Allenby et al., QOL
measures traditionally are collected by printed self-report
questionnaires and entered into a database manually
[16,90], which, according to McDonald and Barnett, is
still the most commonly used method [91,92]. A study by
Le et al. revealed that this method, however, is fraught
with high labor costs, poor turnaround time, and errors
[76]. Fairly recently, optical mark-recognition systems
have been developed to enhance the transfer of the data
into databases. This form of input can process a large
amount of data and is practical for mailed questionnaires.
Nevertheless, this system has problems, such as requiring
special forms, recognizing multiple answers, missing data,
and examining the database for errors. Velikova et al. and
Allenby et al. report that more recently, electronic means
of administering QOL assessments have been introduced
which combat some of the problems associated with the
printed forms and optically read systems. Results are com-
piled automatically in the database and are available in
real time for clinical use [16,90].
Computerized assessment
Overview
Computerized QOL assessments have several advantages.
They provide more accurate results, and as such, represent
a picture of patients' QOL more clearly. Additionally, the
use of technology to facilitate the implementation of QOL
assessments increases efficiency and allows utilization by
a wider population.
According to a study by Buxton et al., a touch-screen com-
puterized system has advantages over paper-and-pencil
QOL questionnaires, which include the ability to increase
the font size for those with visual difficulties, reduce the
number of missed items, decrease the need for paper, ana-
lyze the patient's information immediately, and easily
store and retrieve the data [93]. Allenby et al. report that
electronic completion of QOL questionnaires also can
reduce the potential of errors with after-survey data input
and can reduce the length of time it takes to administer
the questionnaires [90]. Taenzer et al. [82] found patients
took an average of 8.6 minutes to complete an electronic
version of the EORTC QLQ-C30 questionnaire as
opposed to 11 minutes to complete its paper version. In
another study by Velikova et al. examining the difference
between the electronic version of the EORTC QLQ-C30
and its paper version, patients took less time to complete
the touch-screen version (8.3 minutes) as opposed to the
paper version (9.6 minutes) [16]. Bliven et al. state that
the Internet allows for the collection of patient-reported
data at multiple locations, at frequent time intervals, and
at little cost [94]. It is also reported by Le et al. that touch
screens or pen-based computers are appealing because
they are portable and do not require the respondents to
use a keyboard or a mouse [76].
In a study by Velikova et al. comparing the touch-screen
versions and paper versions of the EORTC QLQ-C30 and
the HADS, the quality of the data extracted from a touch-
screen version was found to be excellent, with no missing
or problematic responses, mainly because the patient
could not progress through the questionnaire without
answering each question. In contrast, 1,032 errors were
reported from the paper version; 357 being patient relatedHealth and Quality of Life Outcomes 2007, 5:24 http://www.hqlo.com/content/5/1/24
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errors (such as missing responses, multiple answers, or
changed answers) and 725 being scanner related errors
(such as not recognizing the responses). More than 92%
of the optically read questionnaires had scanning, verifi-
cation, or database errors, which caused significant addi-
tional work for the research staff who had to check and
verify the quality of the database after each scanning of the
paper questionnaires [16]. The same study found that
52% of the patients surveyed preferred the touch-screen
computer, compared to 24% preferring the paper version.
Overall, 76% of all patients found the computer version
to be acceptable (either preferring it specifically or finding
it as acceptable as the paper version). Administration pref-
erence was not found to be related to age, gender, order of
presentation, or time for completion [16].
In one study by Allenby et al., patients reported the touch-
screen system to be very easy to use in regards to their abil-
ity to read the screen (95% of the patients), entering of an
identification number (76%), following the instructions
(74%), and choosing the appropriate answer (71%) [93].
In another study, 99% of patients found the touch screen
easy to use, 98% stated the instructions were easy to fol-
low, 98% stated the questions were easy to read on the
screen, and 99% stated the time it took to complete the
survey was acceptable [90].
Another study by Taenzer et al. found 41% of women
liked computer-administered questionnaires, 45% were
neutral, and 14% said they did not like such question-
naires. If participants had prior experience with the pro-
gram, their attitudes towards the computer-administered
questionnaire changed, with 80% stating they liked the
method, 11% stating they were neutral, and only 8% stat-
ing they did not like the method [82]. Similarly, Newell et
al. reported that 89% of oncology patients stated they
would be willing to fill out a subsequent touch-screen
questionnaire, with 73% of those patients being over the
age of 50 and 59% having never used a computer before
the assessment [95]. Bliven et al. [94] found that in spite
of nearly half of the respondents stating they had no prior
computer experience, computer literacy was not signifi-
cantly associated with the respondent's ability to com-
plete successfully the computerized questionnaire.
A study by Velikova et al. that examined the use of com-
puter technology in QOL assessments found that primary
outcomes on the FACT-G [45] showed a significant
improvement in the intervention group, who completed
the EORTC QLQ-C30 [42] and the HADS [51] on a touch-
screen computer in the clinic and received feedback from
the physician, as compared to the control group, who did
not complete questionnaires before the visit. With further
analyses, a significant improvement was also detected
between the attention-control group, who completed the
questionnaires but did not receive any feedback from the
physician and the control group. In examining emotional
well-being, the intervention group showed a higher score
than the control. No difference was found, however,
between the attention-control and control groups. Those
patients who decided not to complete the study had a sig-
nificantly lower FACT-G score at baseline than patients
who finished the study. A sizeable percentage of patients
in the intervention group had significant improvement in
QOL after only three visits. The average number of visits
needed for one person to benefit was 4.2 [83].
In examining the transcripts of the visits in the above-
mentioned study, it was found that the intervention group
had a higher number of EORTC QLQ-C30 symptoms
being discussed than the control group. More discussion
of chronic symptoms, such as difficulty sleeping, lack of
appetite, and fatigue were observed without extending the
visits. When QOL data were discussed with patients dur-
ing their third visit, the mean change of the FACT-G score
was higher than when QOL data were not mentioned
[83].
Problems with computerized assessment
Velikova et al. found that patients had difficulty with the
handheld computers because of the small screens as well
as the software design, which prevented the patients from
changing their answers. The handheld computers also had
technical difficulties resulting in unreliable downloaded
data and administrative problems in ensuring the security
of the portable computers and the data contained within
them [16]. Entering the demographic information on the
touch-screen computer was difficult and time consuming
because if patients made a mistake, they would have to
delete their responses and start again.
Another study by Buxton et al. found 23% of patients had
problems using the touch-screen because of its lack of
appropriate responsiveness to touch due to the wearing-
down of equipment towards the end of the study [93]. It
would be of importance to include potential users of QOL
assessments from the beginning to determine confound-
ing issues and correct them before implementation of the
system.
Discussion
Overview
The overarching purpose of this review has been to add to
the scientific literature by revealing how the implementa-
tion of QOL assessments into clinical practice would ben-
efit the overall QOL of patients, by evaluating the
acceptability of QOL assessments among healthcare pro-
fessionals, by addressing how QOL assessments can be
utilized, by suggesting solutions to the challenges of
implementation, and by revealing how technology canHealth and Quality of Life Outcomes 2007, 5:24 http://www.hqlo.com/content/5/1/24
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improve the accuracy of QOL assessments and facilitate
their implementation into oncology practices.
The overall acceptability and benefits of QOL assessments 
for breast cancer patients
QOL assessments have found acceptability among physi-
cians, nurses, and psychosocial staff for several reasons.
QOL assessments benefit breast cancer patients because
they provide insights into life domains affected by breast
cancer that are usually unaddressed, including a patient's
mental health, emotional well-being, family and social
relations, and abilities to maintain a career, uphold
finances, and pursue leisure activities. This knowledge is
significant because many breast cancer patients stress that
quality of life is just as important, if not more important,
than quantity of life.
The effort that physicians take to inquire about QOL
improves doctor-patient communication and shows
patients that their physicians care about them and are
interested in their well-being. To patients, this is highly
meaningful.
Future directions in the field of QOL assessments for breast 
cancer patients
Suggestions for the implementation of QOL assessments
Future implementation will not work by simply adding
QOL measurements to the other daily tasks completed by
the oncology staff. In order to provide timely response to
patients' needs, QOL should be embedded into the care
process of patient reported outcomes by redesigning care,
particularly by paying attention to principles of effective
distribution as well as implementing new infrastructures
and technologies [18].
In order to have the ideal assessment system, it must be
clinically relevant (useful and presented in a timely man-
ner), sensitive to change, culturally sensitive, low burden,
low in cost, built into the standard operating procedures,
and meet regulatory, consumer, and community require-
ments [96]. QOL measures must be easily implemented
Table 1: Suggested solutions to overcome the challenges of implementing QOL assessments into clinical practice
Challenges Solutions
Instrument characteristics
QOL assessments provide "soft data." Support the implementation of QOL assessments, as the soft data provides 
additional insights into a patient's health, as it provides qualitative data in addition to 
the quantitative data provided by "hard" measurement.
The types of questions asked can be too sensitive, personal, 
or irrelevant.
It is recommended that, when developing questionnaires, potential questions be 
tested by a population of elderly patients to gauge respondents' sensitivity and how 
effectively the questions measure a patient's QOL.
Patient population
Questionnaires do not assess long-term survivors (over 5 
years) – only 1 year survivors.
Long-term survivors of more than 5 years should be included in the original 
development and testing of instruments.
Among the elderly, there is illiteracy, worse compliance with 
questionnaires, and cognitive disorders.
The option of questionnaires administered in an interview format should be available 
to elderly patients. This solution would address compliance. In addition, it would 
address illiteracy and cognitive disorders, because the questionnaires could be read 
to the respondents, explained, and discussed with them.
Healthcare professionals
Physicians are less familiar with how to utilize QOL 
assessments and how to interpret or respond to results.
Training classes about the importance, potential benefits, proper utilization of QOL 
assessments, interpretation of results, and appropriate action to be taken are 
recommended to be offered at medical schools and through Continuing Medical 
Education courses. To help better understand their utilization, healthcare providers 
could be taught whom the appropriate specialists to refer their patients would be 
based on the results of the QOL assessments.
Physicians do not have the proper tools needed to make 
QOL assessments part of their practice.
QOL assessments could be made accessible through online availability, allowing 
physicians to have a centralized location to download efficiently instruments as 
needed.
Logistics and resources
Time limitations exist. Questionnaires could be administered while the patient is waiting to be seen by the 
physician.
Measures are usually reported manually, which leads to 
inaccurate results and a long turnaround time.
The utilization of computerized assessments would improve the accuracy of QOL 
assessments and increase the efficiency of their use.
Computerized assessment
Respondents may be unfamiliar with how to use computers 
or touchpad personal computers (PCs).
Brief training sessions of 10–15 minutes could be held while patients are in waiting 
rooms, where respondents would learn by the administrator how to manipulate the 
mouse, keyboard, and touchpad.
The programming of some questionnaires makes it difficult 
for patients to change their answers.
Efforts could be made to modify computer programming and software to facilitate 
computerized administration of questionnaires.Health and Quality of Life Outcomes 2007, 5:24 http://www.hqlo.com/content/5/1/24
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into the medical office routine [93], requiring that they be
short, easy to interpret, and not require intricate training
or scoring [77,93]. These assessments need to be accepta-
ble to the patients and be able to produce reports in real
time without disrupting busy clinics [76]. Because of time
constraints, patients, physicians, and office staff are not
always willing to incorporate something new into their
clinical routine [97]. Providing interpretations and rec-
ommendations about available resources and the score
may be helpful rather than just providing the physician
with a functional status score [77].
Suggested solutions to address challenges to implementation
While many healthcare professionals agree about the ben-
efits of QOL assessments, few implement these measures
because of the barriers presented. Table 1 provides sug-
gested solutions to address the specific challenges to the
implementation of QOL measurements in oncology prac-
tices.
The use of technology to facilitate the implementation of 
QOL assessments into clinical practice
Utilizing technology to implement QOL assessments into
clinical practice has several advantages and makes it more
feasible for physicians to use QOL information with their
patients. Touch-screen computers facilitate use by
patients, and those who have used this method favor it.
Electronic methods of assessment are more accurate and
less time-consuming than paper-and pencil question-
naires.
Conclusion
In conclusion, we found that QOL assessment tools,
including written assessments and computer assessments,
have several advantages and are beneficial for breast can-
cer patients. The implementation of QOL assessments
into clinical practice for breast cancer treatment has a high
potential to benefit patients. Health-related quality of life
has increasingly been an important factor to consider in
the holistic treatment of breast cancer patients, and by
providing accurate insights into QOL through self-
reported questionnaires, physicians will be better able to
make treatment decisions. Technologies can provide a
highly efficient and accurate means of implementing QOL
assessments so that they can help a wider range of breast
cancer patients.
Physicians, nurses, and psychosocial staff recognize the
merits of QOL assessments [26-28]. The advantages of
implementing QOL tools are further supported by studies
comparing intervention groups and controls, which have
found that the intervention groups received more coun-
seling and meaningful discussion with physicians. The
information and advice gained in these counseling ses-
sions have several benefits. In addition to learning about
breast cancer, patients gain an understanding of how to
best use the advice they received to improve the quality of
their own lives. Because QOL instruments provide accu-
rate assessments of the well-being and functionality of
patients, utilizing them in clinical practice would signifi-
cantly benefit patients and provide them with insights
into their own care. Future studies involving the QOL of
breast cancer patients should examine emerging science
surround the implementation of QOL instruments, such
as computerized versions and telephone-based applica-
tions, to enhance and streamline the assessment-taking
process for both the patient as well as the medical staff. In
order to create the most reliable and user-friendly applica-
tion, potential users of the software should be included
from the beginning to determine where possible prob-
lems might lie. Careful selection of the QOL assess-
ment(s) should be considered with each population being
examined to provide a reliable and valid patient-reported
outcome.
Additional material
References
1. National Center for Health Statistics CDCP: US Mortality Public
Use Data Tapes, 1969-2003.  2006.
2. American Cancer Society: Cancer Statistics 2006:  A Presena-
tion from the American Cancer Society.  2006.
3. Tracy GE: Breast cancer--the disease many women fear the
most.  S D J Med 2004, 57(4):148.
4. Ries LAG Harkins, D, Krapcho, M, et al.: SEER Cancer Statistics
Review, 1975-2003.  2006.
5. Pfizer Oncology: Breast Cancer Fact Sheet.  2006.
6. Lipscomb J, Donaldson MS, Hiatt RA: Cancer Outcomes
Research and the Arenas of Application.  J Natl Cancer Inst Mon-
ographs 2004, 2004(33):1-7.
7. Brown ML, Lipscomb J, Snyder C: The burden of illness of cancer:
economic cost and quality of life.  Annu Rev Public Health 2001,
22:91-113.
8. American Cancer Society ISDH Indiana Cancer Consortium: Indiana
Cancer Facts and Figures 2006:  A sourcebook for planning
and implementing programs for cancer prevention and con-
trol.  2006.
9. Hewitt M Herdman, R., and Holland, J., Editors, National Research
Council: Meeting Psychosocial Needs of Women with Breast
Cancer.  2004:229-233.
10. Seidman AD, Portenoy R, Yao TJ, Lepore J, Mont EK, Kortmansky J,
Onetto N, Ren L, Grechko J, Beltangady M, et al.: Quality of life in
phase II trials: a study of methodology and predictive value
in patients with advanced breast cancer treated with paclit-
axel plus granulocyte colony-stimulating factor.  J Natl Cancer
Inst 1995, 87(17):1316-1322.
11. Wen KY, Gustafson DH: Needs assessment for cancer patients
and their families.  Health Qual Life Outcomes 2004, 2:11.
12. Sharpe L, Butow P, Smith C, McConnell D, Clarke S: Changes in
quality of life in patients with advanced cancer: Evidence of
Additional file 1
Appendix A. Characteristics of generic and breast cancer-specific quality 
of life instruments (Instruments are listed alphabetically).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1477-
7525-5-24-S1.doc]Health and Quality of Life Outcomes 2007, 5:24 http://www.hqlo.com/content/5/1/24
Page 12 of 14
(page number not for citation purposes)
response shift and response restriction.  Journal of Psychosomatic
Research 2005, 58:497-504.
13. Ganz PA: Quality of life measures in cancer chemotherapy:
Methodology and implications.  Pharmacoeconomics 1994,
5:376-388.
14. Strain JJ: The evolution of quality of life evaluations in cancer
therapy.  Oncology 1990, 4:22-26.
15. Karnofsky DA, Abelmann WH, Craver LF, Burchenal JH: The use of
the nitrogen mustards in the palliative treatment of carci-
noma.  Cancer 1948:634-656.
16. Velikova G, Wright EP, Smith AB, Cull A, Gould A, Forman D, Perren
T, Stead M, Brown J, Selby PJ: Automated collection of quality-
of-life data: A comparison of paper and computer touch-
screen questionnaires.  Journal of Clinical Oncology 1999,
17(3):998-1007.
17. Ganz PA, Goodwin PJ: Quality of Life in Breast Cancer: What
Have We Learned and Where Do We Go from Here?  In Out-
comes Assessment in Cancer: Measures, Methods, and Applications Edited
by: Lipscomb J, Gotay CC, Snyder C. Cambridge, United Kingdom ,
Cambridge University Press; 2005:93-125. 
18. Donaldson MS: Taking stock of health-related quality-of-life
measurement in oncology practice in the United States.  Jour-
nal of the National Cancer Institute Monographs 2004:155-167.
19. Goodwin PJ, Black JT, Bordeleau LJ, Ganz PA: Health-related qual-
ity-of-life measurement in randomized clinical trials in
breast cancer - Taking stock.  Journal of the National Cancer Insti-
tute 2003, 95(4):263-281.
20. Mandelblatt J, Armetta C, Yabroff KR, Liang W, Lawrence W:
Descriptive review of the literature on breast cancer out-
comes: 1990 through 2000.  Journal of the National Cancer Institute
Monographs 2004, 33:8-44.
21. Rosser JE, Maguire P: Dilemmas in General-Practice - the Care
of the Cancer-Patient.  Social Science and Medicine 1982,
16(3):315-322.
22. Maguire P: Barriers to Psychological Care of the Dying.  British
Medical Journal 1985, 291(6510):1711-1713.
23. Schor EL, Lerner DJ, Malspeis S: Physicians' assessment of func-
tional health status and well-being.  Archives of Internal Medicine
1995, 155:309-314.
24. Wagner AK, Ehrenberg BL, Tran TA, Bungay KM, Cynn DJ, Rogers
WH:  Patient-based health status measurement in clinical
practice: A study of its impact on epilepsy patients' care.
Quality of Life Research 1997, 6(4):329-341.
25. Greenhalgh J, Meadows K: The effectiveness of the use of
patient-based measures of health in routine practice in
improving the process and outcomes of patient care: a liter-
ature review.  Journal of Evaluation in Clinical Practice 1999,
5(4):401-416.
26. Finlay IG, Dunlop R: Quality of life assessment in palliative care.
Annals of Oncology 1994, 5(1):13-18.
27. Ganz PA: Impact of quality of life outcomes on clinical prac-
tice.  Oncology 1995, 9(11):61-65.
28. Bezjak A, Ng P, Taylor KM, Macdonald K, Depetrillo AD: A prelim-
inary survey of oncologists perceptions of quality of life infor-
mation.  Psycho-Oncology 1997, 6:107-113.
29. Sprangers MA, Schwarz CE: Integrating response shift into
health-related quality of life research: A theoretical model.
Social Science and Medicine 1999, 48:1507-1515.
30. Beck AT, Steer RA, Garbin MG: Psychometric properties of the
Beck Depression Inventory: Twenty-five Years of Evaluation.
Clinical Psychology Review 1988, 8:77-100.
31. Levine MN, Guyatt GH, Gent M, De Pauw S, Goodyear MD, Hryniuk
WM, Arnold A, Findlay B, Skillings JR, Bramwell VH, et al.: Quality of
life in stage II breast cancer: an instrument for clinical trials.
Journal of Clinical Oncology 1988, 6(12):1798-1810.
32. Ganz PA, Day R, Ware JE Jr., Redmond C, Fisher B: Base-line qual-
ity-of-life assessment in the National Surgical Adjuvant
Breast and Bowel Project Breast Cancer Prevention Trial.  J
Natl Cancer Inst 1995, 87(18):1372-1382.
33. Day R, Ganz PA, Costantino JP, Cronin WM, Wickerham DL, Fisher
B: Health-related quality of life and tamoxifen in breast can-
cer prevention: a report from the National Surgical Adju-
vant Breast and Bowel Project P-1 Study.  Journal of Clinical
Oncology 1999, 17(9):2659-2669.
34. Lattimore-Foot GG: Needs assessment in tertiary and second-
ary oncology practice: a conceptual and methodological
exposition.   PhD thesis. University of Newcastle, Newcastle; 1996. 
35. Cossich T, Schofield P, McLachlan SA: Validation of the cancer
needs questionnaire (CNQ) short-form version in an ambu-
latory cancer setting.  Qual Life Res 2004, 13(7):1225-1233.
36. Heinrich RL, Schag CC, Ganz PA: Living with cancer: the Cancer
Inventory of Problem Situations.  Journal of Clinical Psychology
1984, 40(4):972-980.
37. Turner J, Kelly B, Swanson C, Allison R, Wetzig N: Psychosocial
impact of newly diagnosed advanced breast cancer.  Psycho-
Oncology 2005, 14(5):396-407.
38. Radloff LS: The CES-D scale: A self-report depression scale for
research in the general population.  Applied Psychological Meas-
urement 1977, 1:385-401.
39. Irwin M, Artin KH, Oxman MN: Screening for depression in the
older adult: criterion validity of the 10-item Center for Epi-
demiological Studies Depression Scale (CES-D).  Archives of
Internal Medicine 1999, 159(15):1701-1704.
40. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K: The Edmon-
ton Symptom Assessment System (ESAS): a simple method
for the assessment of palliative care patients.  Journal of Pallia-
tive Care 1991, 7(2):6-9.
41. Chang VT, Hwang SS, Feuerman M: Validation of the Edmonton
Symptom Assessment Scale.  Cancer 2000, 88(9):2164-2171.
42. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ,
Filiberti A, Flechtner H, Fleishman SB, Dehaes J, Kaasa S, Klee M,
Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda
F:  The European-Organization-for-Research-and-Treat-
ment-of-Cancer QLQ-C30 - a Quality-of-Life Instrument for
Use in International Clinical-Trials in Oncology.  Journal of the
National Cancer Institute 1993, 85(5):365-376.
43. McLachlan SA, Devins GM, Goodwin PJ: Validation of the Euro-
pean Organization for Research and Treatment of Cancer
Quality of Life Questionnaire (QLQ-C30) as a measure of
psychosocial function in breast cancer patients.  European Jour-
nal of Cancer 1998, 34(4):510-517.
44. Sprangers MAG, Groenvold M, Arraras JI, Franklin J, teVelde A,
Muller M, Franzini L, Wiliams A, deHaes H, Hopwood P, Cull A, Aar-
onson NK: The European Organization for Research and
Treatment of Cancer breast cancer-specific quality-of-life
questionnaire module: First results from a three-country
field study.  Journal of Clinical Oncology 1996, 14(10):2756-2768.
45. Brady MJ, Cella DF, Mo F, Bonomi AE, Tulsky DS, Lloyd SR, Deasy S,
Cobleigh M, Shiomoto G: Reliability and validity of the Func-
tional Assessment of Cancer Therapy-Breast quality-of-life
instrument.  Journal of Clinical Oncology 1997, 15(3):974-986.
46. Yost KJ, Yount SE, Eton DT, Silberman C, Broughton-Heyes A, Cella
D: Validation of the Functional Assessment of Cancer Ther-
apy-Breast Symptom Index (FBSI).  Breast Cancer Res Treat
2005, 90(3):295-298.
47. Fallowfield LJ, Leaity SK, Howell A, Benson S, Cella D: Assessment
of quality of life in women undergoing hormonal therapy for
breast cancer: validation of an endocrine symptom subscale
for the FACT-B.  Breast Cancer Research and Treatment 1999,
55(2):189-199.
48. Morrow GR, Lindke J, Black P: Measurement of quality of life in
patients: psychometric analyses of the Functional Living
Index-Cancer (FLIC).  Quality of Life Research 1992, 1(5):287-296.
49. Sheikh J, Yesavage J: Geriatric Depression Scale: Recent evi-
dence and development of a shorter version.  Clinical Gerontol-
ogist 1986, 5:165-173.
50. Lesher EL, Berryhill JS: Validation of the Geriatric Depression
Scale--Short Form among inpatients.  Journal of Clinical Psychol-
ogy 1994, 50(2):256-260.
51. Zigmond AS, Snaith RP: The hospital anxiety and depression
scale.  Acta Psychiatrica Scandinavica 1983, 67(6):361-370.
52. Bjelland I, Dahl AA, Haug TT, Neckelmann D: The validity of the
Hospital Anxiety and Depression Scale. An updated litera-
ture review.  Journal of Psychosomatic Research 2002, 52(2):69-77.
53. Carlsson M, Hamrin E: Measurement of quality of life in women
with breast cancer. Development of a Life Satisfaction Ques-
tionnaire (LSQ-32) and a comparison with the EORTC QLQ-
C30.  Quality of Life Research 1996, 5(2):265-274.Health and Quality of Life Outcomes 2007, 5:24 http://www.hqlo.com/content/5/1/24
Page 13 of 14
(page number not for citation purposes)
54. Ware J, Snow K, Kosinski M: SF-36 Health Survey: Manual and
Interpretation Guide.  Lincoln, RI , Quality-Metric Incorporated;
1993. 
55. Failde I, Ramos I: Validity and reliability of the SF-36 Health
Survey Questionnaire in patients with coronary artery dis-
ease.  Journal of Clinical Epidemiology 2000, 53(4):359-365.
56. Stein KD, Denniston M, Baker F, Dent M, Hann DM, Bushhouse S,
West M: Validation of a modified Rotterdam Symptom
Checklist for use with cancer patients in the united states.
Journal of Pain and Symptom Management 2003, 26(5):975-989.
57. Spagnola S, Zabora J, BrintzenhofeSzoc K, Hooker C, Cohen G, Baker
F: The Satisfaction with Life Domains Scale for Breast Can-
cer (SLDS-BC).  Breast J 2003, 9(6):463-471.
58. Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R,
Battista RN, Catchlove BR: Measuring the quality of life of can-
cer patients: a concise QL-index for use by physicians.  Journal
of Chronic Diseases 1981, 34(12):585-597.
59. Development of the World Health Organization WHO-
QOL-BREF quality of life assessment. The WHOQOL
Group.  Psychol Med 1998, 28(3):551-558.
60. da Silva Lima AF, Fleck M, Pechansky F, de Boni R, Sukop P: Psycho-
metric properties of the World Health Organization quality
of life instrument (WHOQoL-BREF) in alcoholic males: a
pilot study.  Quality of Life Research 2005, 14(2):473-478.
61. Zung WW: A Self-Rating Depression Scale.  Archives of General
Psychiatry 1965, 12:63-70.
62. Thurber S, Snow M, Honts CR: The Zung Self-Rating Depression
Scale: convergent validity and diagnostic discrimination.
Assessment 2002, 9(4):401-405.
63. Jacobsen PB, Davis K, Cella D: Assessing quality of life in
research and clinical practice.  Oncology (Williston Park) 2002,
16(9 Suppl 10):133-139.
64. Magruder-Habib K, Zung WWK: Improving Physicians Recogni-
tion and Treatment of Depression in General Medical-Care
- Results from a Randomized Clinical-Trial.  Medical Care 1990,
28(3):239-250.
65. Rubenstein LV, McCoy JM, Cope DW, Barrett PA, Hirsch SH, Messer
KS, Young RT: Improving patient quality of life with feedback
to physicians about functional status.  Journal of General Internal
Medicine 1995, 10(11):607-614.
66. Gold I, Baraff LJ: Psychiatric Screening in the Emergency
Department - Its Effect on Physician Behavior.  Annals of Emer-
gency Medicine 1989, 18(8):875-880.
67. Mazonson PD, Mathias SD, Fifer SK, Buesching DP, Malek P, Patrick
DL: The mental health patient profile: does it change pri-
mary care physicians' practice patterns?  Journal of the American
Board of Family Practice 1996, 9(5):336-345.
68. Detmar SB, Muller MJ, Schornagel JH, Wever LDV, Aaronson NK:
Health-related quality-of-life assessments and patient-physi-
cian communication - A randomized controlled trial.  Jama-
Journal of the American Medical Association 2002, 288(23):3027-3034.
69. Street RL, Gold WR, McDowell T: Using Health-Status Surveys
in Medical Consultations.  Medical Care 1994, 32(7):732-744.
70. Wasson J, Hays R, Rubenstein L, Nelson E, Leaning J, Johnson D, Kel-
ler A, Landgraf J, Rosenkrans C: The short-term effect of patient
health status assessment in a health maintenance organiza-
tion.  Qual Life Res 1992, 1(2):99-106.
71. Rubenstein LV, Calkins DR, Young RT, Cleary PD, Fink A, Kosecoff J,
Jette AM, Davies AR, Delbanco TL, Brook RH: Improving Patient
Function - a Randomized Trial of Functional Disability
Screening.  Annals of Internal Medicine 1989, 111(10):836-842.
72. Kazis LE, Callahan LF, Meenan RF, Pincus T: Health-Status Reports
in the Care of Patients with Rheumatoid-Arthritis.  Journal of
Clinical Epidemiology 1990, 43(11):1243-1253.
73. Taenzer P, Bultz BD, Carlson LE, Speca M, DeGagne T, Olson K, Doll
R, Rosberger Z: Impact of computerized quality of life screen-
ing on physician behaviour and patient satisfaction in lung
cancer outpatients.  Psycho-Oncology 2000, 9:203-213.
74. Bendtsen P, Leijon M, Sommer AS, Kristenson M: Measuring
health-related quality of life in patients with chronic obstruc-
tive pulmonary disease in a routine hospital setting: Feasibil-
ity and perceived value.  Health and Quality of Life Outcomes 2003,
1:5.
75. Di Maio M, Perrone F: Quality of Life in elderly patients with
cancer.  Health Qual Life Outcomes 2003, 1(1):44.
76. Le PP, Kohane IS, Weeks JC: Using a pen-based computer to col-
lect health-related quality of life and utilities information.
Proceedings of the 19th Annual Symposium on Computer Application in
Medical Care 1995:839-842.
77. Deyo RA, Carter WB: Strategies for Improving and Expanding
the Application of Health-Status Measures in Clinical Set-
tings - a Researcher Developer Viewpoint.  Medical Care 1992,
30(5):Ms176-Ms186.
78. Middeke M, Bauhofer A, Koller M: Computerized visualization of
quality of life data of individual cancer patients - the QoL-
Profiler.  Inflammation Research 2004, 53(Supplement
2):S175-S178.
79. Donaldson M: Using patient-reported outcomes in clinical
oncology practice:  benefits, challenges and next steps.  Expert
Rev Pharmacoeconomics Outcomes Res 2006, 6(1):87-95.
80. Moore AA, Siu AL, Partridge JM, Hays RD, Adams J: A randomized
trial of office-based screening for common problems in older
persons.  American Journal of Medicine 1997, 102(4):371-378.
81. Dowrick C: Does testing for depression influence diagnosis or
management by general practitioners?  Family Practice 1995,
12(4):461-465.
82. Taenzer PA, Speca M, Atkinson MJ, Bultz BD, Page S, Harasym P,
Davis JL: Computerized quality-of-life screening in an oncol-
ogy clinic.  Cancer Practice 1997, 5(3):168-175.
83. Velikova G, Booth L, Smith AB, Brown PM, Lynch P, Brown JM, Selby
PJ:  Measuring quality of life in routine oncology practice
improves communication and patient well-being: A rand-
omized controlled trial.  Journal of Clinical Oncology 2004,
22(4):714-724.
84. Stiggelbout AM, De Haes JCJM, Kiebert GM, Kievit J, Leer JWH:
Tradeoffs between Quality and Quantity of Life: Develop-
ment of the QQ Questionnaire for Cancer Patient Attitudes.
Med Decis Making 1996, 16(2):184-192.
85. Apolone G, Filiberti A, Cifani S, Ruggiata R, Mosconi P: Evaluation
of the EORTC QLQ-C30 questionnaire: a comparison with
SF-36 Health Survey in a cohort of Italian long-survival can-
cer patients.  Ann Oncol 1998, 9(5):549-557.
86. Pijls-Johannesma MC, Pijpe A, Kempen GI, Lambin P, Dagnelie PC:
Health related quality of life assessment instruments: a pro-
spective study on preference and acceptability among can-
cer patients referred for radiotherapy.  Eur J Cancer 2005,
41(15):2250-2256.
87. Morris J, Perez D, McNoe B: The use of quality of life data in clin-
ical practice.  Qual Life Res 1998, 7(1):85-91.
88. Maguire P, Faulkner A, Booth K, Elliott C, Hillier V: Helping cancer
patients disclose their concerns.  European Journal of Cancer 1996,
32A(1):78-81.
89. Gotay CC, Korn EL, McCabe MS, Moore TD, Cheson BD: Quality-
of-life assessment in cancer treatment protocols: research
issues in protocol development.  J Natl Cancer Inst 1992,
84(8):575-579.
90. Allenby A, Matthews J, Beresford J, McLachlan SA: The application
of computer touch-screen technology in screening for psy-
chosocial distress in an ambulatory oncology setting.  Euro-
pean Journal of Cancer Care 2002, 11(4):245-253.
91. McDonald C, Barnett G: Medical-record systems.  In Medical Infor-
matics: Computer Applications in Health Care Volume 1. Edited by: Short-
liffe E. Boston, MA , Addison-Wesley Longman Publishing Co., Inc.;
1990. 
92. Wilton R, Pennisi AJ: Evaluating the accuracy of transcribed
clinical data. Preceedings of the symposium on computer
applications in medical care.  American Medical Informatics Associ-
ation 1993:279-283.
93. Buxton J, White M, Osoba D: Patients' experiences using a com-
puterized program with a touch-sensitive video monitor for
the assessment of health-related quality of life.  Quality of Life
Research 1998, 7(6):513-519.
94. Bliven BD, Kaufman SE, Spertus JA: Electronic collection of
health-related quality of life data: Validity, time benefits, and
patient preference.  Quality of Life Research 2001, 10:15-22.
95. Newell S, Girgis A, Sanson-Fisher R, Stewart J: Are touchscreen
computer surveys acceptable to medical oncology patients.
Journal of Psychosocial Oncology 1997, 15:37-46.
96. Sederer LI, Dickey B, Eisen SV: Assessing outcomes in clinical
practice.  Psychiatric Quarterly 1997, 68(4):311-325.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Health and Quality of Life Outcomes 2007, 5:24 http://www.hqlo.com/content/5/1/24
Page 14 of 14
(page number not for citation purposes)
97. Wasson J, Keller A, Rubenstein L, Hays R, Nelson E, Johnson D: Ben-
efits and Obstacles of Health-Status Assessment in Ambula-
tory Settings - the Clinician Point-of-View.  Med Care 1992,
30(5):Ms42-Ms49.